Loading clinical trials...
Loading clinical trials...
A Phase 1/2 Trial of Carfilzomib and Melphalan and Conditioning for Autologous Stem Cell Transplantation for Multiple Myeloma (CARAMEL)
Conditions
Interventions
Autologous Bone Marrow Transplantation
Autologous Hematopoietic Stem Cell Transplantation
+3 more
Locations
2
United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
June 4, 2013
Primary Completion Date
October 11, 2017
Completion Date
October 28, 2019
Last Updated
September 1, 2020
NCT01899326
NCT01936090
NCT00839956
NCT01330173
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions